Login Get Started
Browse Breadcrumb chevron Shares Breadcrumb chevron Healthcare Breadcrumb chevron Biotechnology & Medical Research Breadcrumb chevron Zymeworks Inc
Zymeworks Inc logo

ZYME - Zymeworks Inc Reuters News

$12.62 -0.8  -6.2%

Last Trade - 4:47pm

Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
Sucker Stock
Market Cap £458.6m
Enterprise Value £232.3m
Revenue £16.5m
Position in Universe 3370th / 7396
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement
Charts News Discussions
Reuters News
All News Reuters News Company Announcements
BRIEF-Zymeworks - On Jan 15, Authorized Restructuring With Target Of Reducing Employee Headcount By At Least 25% Across Organization By End Of 2022
Wed 10:10pm News
BRIEF-Zymeworks Provides Corporate Update On Key Strategic Priorities And Outlook For 2022
Wed 9:47pm News
BRIEF-Zymeworks Reports Inducement Grant Under New York Stock Exchange Listed Company Manual Rule
Sat 1:37pm News
BRIEF-ALX Oncology Provides Corporate Update And Highlights Key Milestones In 2022
10th Jan News
ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2022
10th Jan News
BRIEF-Zymeworks Names Biotechnology Industry Leader Kenneth Galbraith As Chair And CEO To Succeed Dr. Ali Tehrani
5th Jan News
BRIEF-Zymeworks Inc First Patient Dosed In South Korea Under Zymeworks And Beigene Collaboration Agreement
9th Dec '21 News
BRIEF-Zymeworks Announces Second Janssen Bispecific Antibody To Begin Clinical Development Utilizing Azymetric And Efect Therapeutic Platforms
1st Dec '21 News
NYSE ORDER IMBALANCE 55044.0 SHARES ON BUY SIDE
30th Nov '21 News
BUZZ-Guggenheim starts coverage of drug developers Merus, MacroGenics
17th Nov '21 News
BRIEF-Zymeworks Names Neil Josephson, M.D., Chief Medical Officer
9th Nov '21 News
BRIEF-Zymeworks Reports 2021 Third Quarter Financial Results
3rd Nov '21 News
Zymeworks Inc reports results for the quarter ended in September - Earnings Summary
3rd Nov '21 News
Zymeworks Inc expected to post a loss of $1.17 a share - Earnings Preview
1st Nov '21 News
Zymeworks Inc expected to post a loss of $1.17 a share - Earnings Preview
30th Oct '21 News
BRIEF-Zymeworks And Alx Oncology Announce First Patient Dosed In Phase 1B/2 Clinical Trial Of Zanidatamab And Evorpacept
5th Oct '21 News
BRIEF-Zymeworks Inc Files For Mixed Shelf Size Not Disclosed
1st Oct '21 News
BUZZ-Street View: Zymeworks' experimental cancer drug could compete with Roche, Merck
17th Sep '21 News
BUZZ-U.S. STOCKS ON THE MOVE-ForgeRock, IronNet, Dutch Bros
16th Sep '21 News
BRIEF-Zymeworks Presents Positive Phase 2 For Gastroesophageal Adenocarcinoma Treatment
16th Sep '21 News
© Stockopedia 2022, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.